Martin Schuster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Schuster has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Thomas Standl
4 shared publicationsAndré Gottschalk
2 shared publicationsStefan Wilhelm
2 shared publicationsA. E. Goetz
Universitätsklinikum Hamburg-Eppendorf
1 shared publicationD. Hermening
Universitätsklinikum Hamburg-Eppendorf
1 shared publicationJürgen Berger
1 shared publication
Latest Publications
- 1 March 2007
- Published by Springer Nature in Der Anaesthesist
- Vol. 56 (3) , 259-271
Kennzahlen der OP-Effizienz
- 1 March 2007
- Published by Springer Nature in Der Anaesthesist
- Vol. 56 (3) , 259-271
Kennzahlen der OP-Effizienz
- 1 January 2006
- Published by Springer Nature in Der Anaesthesist
- Vol. 55 (1) , 26-32
Die Nutzung der Erlösdaten der „DRGs“ für ein externes Benchmarking der anästhesiologischen und intensivmedizinischen Leistungserbringung
Messung und Bewertung der ökonomischen Effizienz klinischer Leistungserbringer sind wichtige, aber weit gehend ungelöste Probleme im Krankenhausmanagement. Auch für anästhesiologische und intensivmedizinische Leistungen kann ein „benchmarking“ mit anderen Leistungserbringern helfen, die eigene Effizienz einzuschätzen. In der vorliegenden Arbeit wird ein Verfahren vorgestellt, wie die Erlösdaten der „diagnosis-related-groups“ (DRGs) genutzt werden können, um einen Fallmix-adjusierten Kostenvergleich der eigenen anästhesiologischen und intensivmedizinischen Kosten mit denen des bundesdeutschen Durchschnittes durchzuführen. Auf der Basis von 19.401 Fällen aus 10 operativen Disziplinen werden die eigenen Kosten mit den bundesweiten Vergleichskosten, die sich aus den DRG-Daten ergeben, verglichen und wesentliche Optimierungshebel diskutiert. Besonderes Augenmerk wird auf die enge Verschränkung operativer, anästhesiologischer sowie intensivmedizinischer Prozessperformance und Kosten gelegt, und die hieraus entstehenden Einschränkungen des Benchmarking-Verfahren werden diskutiert. Measurement and assessment of the economic efficiency of clinical departments is still an unresolved, yet important problem in hospital management. Benchmarking with other providers can help to evaluate one’s own efficacy in anaesthesia and intensive care services. In this article we describe a method for using the diagnosis-related-groups (DRG) cost breakdown data, to achieve a case mix adjusted comparison of own costs for anaesthesia and intensive care services with the average costs in German hospitals. On the basis of 19,401 cases from 10 different surgical departments, we compared our own costs with the German-wide benchmark. Major factors for profit optimisation are discussed. Special attention is given to the close interaction of surgical, anaesthesiological and intensive care process performance and costs and its impact on benchmarking studies.
- 1 January 2006
- Published by Springer Nature in Der Anaesthesist
- Vol. 55 (1) , 26-32
Die Nutzung der Erlösdaten der „DRGs“ für ein externes Benchmarking der anästhesiologischen und intensivmedizinischen Leistungserbringung
Messung und Bewertung der ökonomischen Effizienz klinischer Leistungserbringer sind wichtige, aber weit gehend ungelöste Probleme im Krankenhausmanagement. Auch für anästhesiologische und intensivmedizinische Leistungen kann ein „benchmarking“ mit anderen Leistungserbringern helfen, die eigene Effizienz einzuschätzen. In der vorliegenden Arbeit wird ein Verfahren vorgestellt, wie die Erlösdaten der „diagnosis-related-groups“ (DRGs) genutzt werden können, um einen Fallmix-adjusierten Kostenvergleich der eigenen anästhesiologischen und intensivmedizinischen Kosten mit denen des bundesdeutschen Durchschnittes durchzuführen. Auf der Basis von 19.401 Fällen aus 10 operativen Disziplinen werden die eigenen Kosten mit den bundesweiten Vergleichskosten, die sich aus den DRG-Daten ergeben, verglichen und wesentliche Optimierungshebel diskutiert. Besonderes Augenmerk wird auf die enge Verschränkung operativer, anästhesiologischer sowie intensivmedizinischer Prozessperformance und Kosten gelegt, und die hieraus entstehenden Einschränkungen des Benchmarking-Verfahren werden diskutiert. Measurement and assessment of the economic efficiency of clinical departments is still an unresolved, yet important problem in hospital management. Benchmarking with other providers can help to evaluate one’s own efficacy in anaesthesia and intensive care services. In this article we describe a method for using the diagnosis-related-groups (DRG) cost breakdown data, to achieve a case mix adjusted comparison of own costs for anaesthesia and intensive care services with the average costs in German hospitals. On the basis of 19,401 cases from 10 different surgical departments, we compared our own costs with the German-wide benchmark. Major factors for profit optimisation are discussed. Special attention is given to the close interaction of surgical, anaesthesiological and intensive care process performance and costs and its impact on benchmarking studies.
- 1 March 2005
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 100 (3) , 786-794
A Retrospective Comparison of Costs for Regional and General Anesthesia Techniques
In this retrospective study, we compared the costs for three different regional anesthesia techniques with the costs of general anesthesia (GA). A total of 1587 anesthesia cases which were performed for orthopedic and trauma patients over a 1-yr period in a tertiary level, university hospital setting were analyzed. The anesthesia technique-related costs were determined calculating case-specific costs for personnel, supplies, and drugs. The techniques were compared on the basis of anesthesia costs and surgical procedure duration. As a result, we found that the costs per surgical minute largely depend on the surgical procedure duration. Based on the regression function, the cost advantage of spinal anesthesia over GA can be estimated to be 13% for a 50-min case, 9% for a 100-min case, and 5% for a 200-min case. The cost disadvantage of brachial plexus anesthesia over GA can be estimated to be 19% for a 50-min case, 8% in a 100-min case, and 1% for a 200-min case. We found no difference in costs between epidural and GA. We concluded that cost comparisons of anesthesia techniques largely depend on the surgical duration of the cases studied. Even in a teaching hospital setting, spinal anesthesia has economic advantages over GA. Especially for short cases, brachial plexus block is more expensive in this setting.
- 1 March 2005
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 100 (3) , 786-794
A Retrospective Comparison of Costs for Regional and General Anesthesia Techniques
In this retrospective study, we compared the costs for three different regional anesthesia techniques with the costs of general anesthesia (GA). A total of 1587 anesthesia cases which were performed for orthopedic and trauma patients over a 1-yr period in a tertiary level, university hospital setting were analyzed. The anesthesia technique-related costs were determined calculating case-specific costs for personnel, supplies, and drugs. The techniques were compared on the basis of anesthesia costs and surgical procedure duration. As a result, we found that the costs per surgical minute largely depend on the surgical procedure duration. Based on the regression function, the cost advantage of spinal anesthesia over GA can be estimated to be 13% for a 50-min case, 9% for a 100-min case, and 5% for a 200-min case. The cost disadvantage of brachial plexus anesthesia over GA can be estimated to be 19% for a 50-min case, 8% in a 100-min case, and 1% for a 200-min case. We found no difference in costs between epidural and GA. We concluded that cost comparisons of anesthesia techniques largely depend on the surgical duration of the cases studied. Even in a teaching hospital setting, spinal anesthesia has economic advantages over GA. Especially for short cases, brachial plexus block is more expensive in this setting.
- 17 December 2004
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 1 (1) , 84
Abdominelles Kompartment-Syndrom (Antwortbogen)
- 17 December 2004
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 1 (1) , 84
Abdominelles Kompartment-Syndrom (Antwortbogen)
- 17 December 2004
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 1 (1) , 82-83
Abdominelles Kompartment-Syndrom (Fragebogen)
- 17 December 2004
- Published by Georg Thieme Verlag KG in Intensivmedizin up2date
- Vol. 1 (1) , 82-83
Abdominelles Kompartment-Syndrom (Fragebogen)
- 1 March 2004
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (3) , 708-713
Cost Drivers in Patient-Controlled Epidural Analgesia for Postoperative Pain Management After Major Surgery
In this retrospective study, we determined efficiency, treatment length, and resource use for postoperative pain management with patient-controlled epidural analgesia (PCEA) in 350 consecutive patients undergoing major abdominal, thoracic, gynecological, or orthopedic surgery. Average pain scores on a visual analog scale were 16 +/- 23 and 9 +/- 16 (visual analog scale range, 0 to 100) on postoperative Days 1 and 3, respectively, and were similar among groups. The treatment length was 4.9 +/- 2.2 days in general surgical, 5.2 +/- 3.1 days in gynecological, and 4.5 +/- 2.8 days in orthopedic patients. The total volumes of the mixture of local anesthetic and opioid received epidurally were 707 +/- 507 mL, 770 +/- 576 mL, and 593 +/- 456 mL in the general surgical, gynecological, and orthopedic groups, respectively. The average total costs for all groups for the full treatment course with PCEA were 447 +/- 218 per case (1 equals approximately US dollar 1). Fifty-one percent of these costs were staff costs, 20% were costs for the applied drugs, 15% were costs for PCEA pumps and pump material, and 13% were costs for the initial catheter insertion. In the light of these costs and the availability of less costly alternatives, measurements for cost containment by using PCEA are recommended. Because treatment length is the main cost driver both for drug and staff costs, close monitoring of treatment length and a predefined migration path to alternative techniques after PCEA should be considered. Patient-controlled epidural analgesia is increasingly used as first-line treatment for postoperative pain management. In this study, costs and cost drivers are analyzed for the first time for this new technique, based on 350 cases of pain therapy after major surgery in a university hospital.
- 1 March 2004
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (3) , 708-713
Cost Drivers in Patient-Controlled Epidural Analgesia for Postoperative Pain Management After Major Surgery
In this retrospective study, we determined efficiency, treatment length, and resource use for postoperative pain management with patient-controlled epidural analgesia (PCEA) in 350 consecutive patients undergoing major abdominal, thoracic, gynecological, or orthopedic surgery. Average pain scores on a visual analog scale were 16 +/- 23 and 9 +/- 16 (visual analog scale range, 0 to 100) on postoperative Days 1 and 3, respectively, and were similar among groups. The treatment length was 4.9 +/- 2.2 days in general surgical, 5.2 +/- 3.1 days in gynecological, and 4.5 +/- 2.8 days in orthopedic patients. The total volumes of the mixture of local anesthetic and opioid received epidurally were 707 +/- 507 mL, 770 +/- 576 mL, and 593 +/- 456 mL in the general surgical, gynecological, and orthopedic groups, respectively. The average total costs for all groups for the full treatment course with PCEA were 447 +/- 218 per case (1 equals approximately US dollar 1). Fifty-one percent of these costs were staff costs, 20% were costs for the applied drugs, 15% were costs for PCEA pumps and pump material, and 13% were costs for the initial catheter insertion. In the light of these costs and the availability of less costly alternatives, measurements for cost containment by using PCEA are recommended. Because treatment length is the main cost driver both for drug and staff costs, close monitoring of treatment length and a predefined migration path to alternative techniques after PCEA should be considered. Patient-controlled epidural analgesia is increasingly used as first-line treatment for postoperative pain management. In this study, costs and cost drivers are analyzed for the first time for this new technique, based on 350 cases of pain therapy after major surgery in a university hospital.